Document is current
Any future updates will be listed below
-
Authors
Halvorsen, Stefan
Thomas, Molly https://orcid.org/0000-0002-1393-6559
Mino-Kenudson, Mari https://orcid.org/0000-0002-9092-2265
Kinowaki, Yuko
Burke, Kristin E.
Morgan, David
Miller, Kaia C. https://orcid.org/0000-0002-3647-7287
Williams, Katherine M.
Gurung, Jenny
McGoldrick, Jessica
Hopton, Megan
Hoppe, Brooke
Samanta, Nandini
Martin, Sidney
Tirard, Alice
Arnold, Benjamin Y.
Tantivit, Jessica
Yarze, Joseph
Staller, Kyle
Chung, Daniel C.
Villani, Alexandra-Chloé https://orcid.org/0000-0001-7461-0408
Sassi, Slim
Khalili, Hamed https://orcid.org/0000-0002-7956-6941
-
Funding
Funding for this research was provided by:
American College of Gastroenterology
U.S. Department of Health & Human Services | National Institutes of Health (DP2CA247831)
- License Information
-
More Information
Article History
Received: 1 September 2022
Accepted: 30 April 2025
First Online: 18 May 2025
Competing interests
: Hamed Khalili has received consulting fees from Aditium Bio and currently serves on the clinical advisory board of Cylinder Health. A.C.V. has a financial interest in 10X Genomics. 10X Genomics designs and manufactures gene sequencing technology for use in research, and such technology is being used in this research; these interests were reviewed by The Massachusetts General Hospital and Mass General Brigham in accordance with their institutional policies. The remaining authors declare no competing interests.
